Reported Jul 29, 2026 · Ongoing · Updated Sep 16, 2026

FARADRIVE STEERABLE SHEATH CLEAR OUS, used to facilitate access to the vasculature and into the chambers of the heart,…

Boston Scientific Corporation

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Boston Scientific Corporation · 4100 Hamline Ave N · Saint Paul, MN · 55112-5700

Is this the product you have?

  • FARADRIVE STEERABLE SHEATH CLEAR OUS, used to facilitate access to the vasculature and into the chambers of the heart, Material Number M004PFCE21M402, IFU Reference Number 51659727-01
Lot codes and dates
  • UDI-DI00191506042516
  • Lots

    131 of 131 codes

    • CL12917
    • CL13004
    • CL13017
    • CL13046
    • CL13060
    • CL13080
    • CL13103
    • CL13122
    • CL13123
    • CL13142
    • CL13160
    • CL13196
    • CL13212
    • CL13219
    • CL13231
    • CL13260
    • CL13291
    • CL13340
    • CL13375
    • CL13401
    • CL13422
    • CL13468
    • CL13519
    • CL13573
    • CL13578
    • CL13614
    • CL13646
    • CL13670
    • CL13671
    • CL13708
    • CL13719
    • CL13722
    • CL13732
    • CL13760
    • CL13801
    • CL13802
    • CL13820
    • CL13833
    • CL13856
    • CL13910
    • CL13911
    • CL13925
    • CL13940
    • CL13971
    • CL13972
    • CL13988
    • CL14025
    • CL14039
    • CL14050
    • CL14051
    • CL14076
    • CL14077
    • CL14119
    • CL14120
    • CL14135
    • CL14137
    • CL14171
    • CL14187
    • CL14226
    • CL14249
Amount recalled
193,000 units

This recall covers 9 products

The agency filed one notice per product. You are reading one of them; the other 8 are below.

Where it was sold

  • Nationwide

Why it was recalled

Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can be mitigated by inserting the dilator straight through the center of the valve and fully advancing it into the sheath body.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Boston Scientific Corporation recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (Enforcement Report)

Read the FDA (weekly enforcement report) notice

Data as of Sep 19, 7:54 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.